Basiliximab may improve the survival rate of rapidly progressive interstitial pneumonia in patients with clinically amyopathic dermatomyositis with anti-MDA5 antibody

✍ Scribed by Zou, Jing (author);Li, Ting (author);Huang, Xingfang (author);Chen, Sheng (author);Guo, Qiang (author);Bao, Chunde (author)

• Book ID: 126463942
• Publisher: BMJ Publishing Group
• Year: 2014
• Tongue: English
• Weight: 874 KB
• Volume: 73
• Category: Article
• ISSN: 0003-4967
• DOI: 10.1136/annrheumdis-2014-205278